First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
April 24, 2024 07:00 ET
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Celiac Disease Diagnostics Market is projected to reach US$ 647.3 Million by the end of 2033, with sales revenue expected to be 8.3% CAGR through 2033 | Future Market Insights, Inc.
May 11, 2023 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, May 11, 2023 (GLOBE NEWSWIRE) -- As per Future Market Insights’ latest industry analysis, the valuation for the global celiac disease diagnostics market was around US$ 271.3 Million in...